Ondansetron
Product Images NDC 67296-1140

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 67296-1140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg (30 Tablets Bottle))

Package Label-principal Display Panel (4 mg (30 Tablets Bottle))
Label for Ondansetron Orally Disintegrating Tablets USP 4 mg, showing product name, dosage strength, and quantity of 30 tablets. The label includes storage instructions, dosage reference, and manufacturer information, indicating distribution by Rising Health, LLC and that it is made in India. A barcode and printing/coding areas are also visible.*
FDA Label Image

Package Label-principal Display Panel (4 mg Blister Carton (3 x 10 Unit-dose))

Package Label-principal Display Panel (4 mg Blister Carton (3 x 10 Unit-dose))
Packaging label for Ondansetron Orally Disintegrating Tablets, USP 4 mg, by Rising Health, LLC, distributed by RedPharm Drug. The label shows the product name, strength, dosage form, and 30 tablets (3 blister cards each containing 10 tablets). It includes usage instructions, storage information, and a barcode. The label also states 'Rx only' and that the tablets are made in India.*
FDA Label Image

Package Label-principal Display Panel (8 mg (30 Tablets Bottle))

Package Label-principal Display Panel (8 mg (30 Tablets Bottle))
Packaging label for Ondansetron Orally Disintegrating Tablets USP 8 mg, containing 30 tablets. The label is from Rising Health, LLC, with a logo of RisingĀ®, and includes storage instructions, phenylalanine content, and distribution information. The label specifies that the product is made in India and includes regulatory and coding areas.*
FDA Label Image

Package Label-principal Display Panel (8 mg Blister Carton (3 x 10 Unit-dose))

Package Label-principal Display Panel (8 mg Blister Carton (3 x 10 Unit-dose))
Rising Ondansetron Orally Disintegrating Tablets, USP 8 mg carton label showing a package of 30 tablets in 3 blister cards of 10 tablets each. The label includes dosage form, strength, manufacturer information (Rising Health, LLC), and storage instructions. The packaging features pictorial instructions for use and warnings, plus a barcode and NDC 57237-078-10.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)
Chemical structure of Ondansetron, showing its molecular framework with indole and imidazole rings connected by a bicyclic ketone-containing moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.